J21.1 Acute bronchiolitis due to human metapneumovirus

Name of the Condition

• Common Names: Acute Bronchiolitis Due to Human Metapneumovirus
• Medical Terms: Acute Bronchiolitis Due to Human Metapneumovirus

Summary

Acute bronchiolitis due to human metapneumovirus is a viral infection of the lower respiratory tract that causes inflammation and obstruction of the small airways (bronchioles) in infants and young children. It is characterized by wheezing, respiratory distress, and often fever. The condition is typically self-limiting but may require medical intervention in severe cases.

Causes

The condition is caused by the human metapneumovirus (hMPV), a common respiratory virus. hMPV is transmitted through respiratory droplets or direct contact with contaminated surfaces. It primarily affects the bronchioles, leading to inflammation and airway obstruction.

Risk Factors

• Age: Most common in infants under 12 months.
• Prematurity or low birth weight.
• Underlying cardiopulmonary disease (e.g., congenital heart defects, chronic lung disease).
• Exposure to tobacco smoke.
• Crowded living conditions or daycare attendance.
• Lack of breastfeeding (reduced passive immunity).

Symptoms

• Cough
• Wheezing or rattling breath sounds
• Rapid or labored breathing
• Nasal congestion
• Low-grade fever
• Poor feeding or dehydration
• Retractions (visible pulling of chest muscles with breathing)

Diagnosis

Diagnosis is primarily clinical, based on history and physical examination findings. Additional tests may include: Nasal swab or respiratory sample to identify the human metapneumovirus. Chest X-ray to assess for signs of bronchiolitis or complications. Oxygen saturation measurement to evaluate respiratory status.

Treatment Options

• Supportive Care: Ensures the child is well-hydrated and maintains adequate oxygen levels.
• Oxygen Therapy: If oxygen levels are low.
• Bronchodilators: May be used in some cases, though evidence of benefit is limited.
• Antiviral Therapy: Not typically used, as hMPV is a virus and treatment focuses on symptom management.

Prognosis and Follow-Up

Most cases resolve within 1-2 weeks with supportive care. Follow-up may be needed for infants with severe symptoms or underlying health conditions to monitor for respiratory improvement or complications. Recurrent wheezing or asthma may occur in some children after bronchiolitis.

Complications

• Respiratory failure requiring mechanical ventilation.
• Secondary bacterial infections (e.g., pneumonia).
• Dehydration from poor feeding.
• Apnea (pauses in breathing), particularly in premature infants.

Lifestyle & Prevention

• Avoid exposure to tobacco smoke.
• Practice good hand hygiene to reduce viral transmission.
• Limit contact with sick individuals, especially in crowded settings.
• Ensure up-to-date vaccinations (e.g., influenza) to reduce co-infections.

When to Seek Professional Help

Seek immediate medical attention if the child exhibits:

• Severe respiratory distress (e.g., grunting, nasal flaring, retractions).
• Difficulty feeding or signs of dehydration (e.g., dry mouth, fewer wet diapers).
• Blue or gray skin, lips, or nail beds.
• Apnea or lethargy.

Tips for Medical Coders

Use code J21.1 for acute bronchiolitis specifically due to human metapneumovirus. Document the viral etiology (e.g., positive hMPV test or clinical suspicion) to support code assignment. Ensure the diagnosis aligns with clinical findings and avoid using this code for unspecified or other viral causes of bronchiolitis.